HF
VBIV

HRT Financial’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

HRT Financial’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-23,811
Closed -$15K – 3298
2023
Q3 		$15K Buy
+23,811
New +$29.2K ﹤0.01% 2094
2023
Q1 		– Sell
-7,038
Closed -$82K – 3414
2022
Q4 		$82K Buy
7,038
+4,312
+158% +$76.1K ﹤0.01% 2086
2022
Q3 		$57K Sell
2,726
-7,538
-73% -$203K ﹤0.01% 2433
2022
Q2 		$248K Buy
+10,264
New +$349K ﹤0.01% 2143
2022
Q1 		– Sell
-2,729
Closed -$191K – 4120
2021
Q4 		$191K Sell
2,729
-11,024
-80% -$929K ﹤0.01% 2552
2021
Q3 		$1.28M Sell
13,753
-3,198
-19% -$304K 0.01% 1059
2021
Q2 		$1.7M Buy
16,951
+13,556
+399% +$1.32M 0.02% 712
2021
Q1 		$316K Buy
+3,395
New +$344K ﹤0.01% 2071

Other funds holding VBIV

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return